Capecitabine is an oral chemotherapeutic agent used primarily in the treatment of colorectal and breast cancers, functioning as a prodrug that is enzymatically converted into 5-fluorouracil (5-FU) in the body. Its targeted action allows for higher concentrations of the active drug in tumor tissues, potentially reducing systemic side effects compared to intravenous 5-FU administration.